Cargando…

Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy

INTRODUCTION: Among high tuberculosis (TB) and HIV burden countries in Asia, tuberculosis preventive therapy (TPT) in people living with HIV (PLWH) has been underutilized despite its proven benefits independent of antiretroviral therapy (ART). Therefore, we determined the incidence of active TB and...

Descripción completa

Detalles Bibliográficos
Autores principales: Suwanpimolkul, Gompol, Gatechompol, Sivaporn, Kawkitinarong, Kamon, Ueaphongsukkit, Thornthun, Sophonphan, Jiratchaya, Siriyakorn, Nirada, Jirajariyavej, Supunnee, Khusuwan, Suwimon, Panarat, Palakorn, Wannalerdsakun, Surat, Saetiew, Natcha, Chayangsu, Sunee, Wiwatrojanagul, Sirichai, Noopetch, Preudtipong, Danpornprasert, Praniti, Mekviwattanawong, Sripetcharat, Fujitnirun, Chris, Lertpiriyasuwat, Cheewanan, Han, Win Min, Kerr, Stephen J., Ruxrungtham, Kiat, Avihingsanon, Anchalee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982319/
https://www.ncbi.nlm.nih.gov/pubmed/35384317
http://dx.doi.org/10.1002/jia2.25900
_version_ 1784681783907844096
author Suwanpimolkul, Gompol
Gatechompol, Sivaporn
Kawkitinarong, Kamon
Ueaphongsukkit, Thornthun
Sophonphan, Jiratchaya
Siriyakorn, Nirada
Jirajariyavej, Supunnee
Khusuwan, Suwimon
Panarat, Palakorn
Wannalerdsakun, Surat
Saetiew, Natcha
Chayangsu, Sunee
Wiwatrojanagul, Sirichai
Noopetch, Preudtipong
Danpornprasert, Praniti
Mekviwattanawong, Sripetcharat
Fujitnirun, Chris
Lertpiriyasuwat, Cheewanan
Han, Win Min
Kerr, Stephen J.
Ruxrungtham, Kiat
Avihingsanon, Anchalee
author_facet Suwanpimolkul, Gompol
Gatechompol, Sivaporn
Kawkitinarong, Kamon
Ueaphongsukkit, Thornthun
Sophonphan, Jiratchaya
Siriyakorn, Nirada
Jirajariyavej, Supunnee
Khusuwan, Suwimon
Panarat, Palakorn
Wannalerdsakun, Surat
Saetiew, Natcha
Chayangsu, Sunee
Wiwatrojanagul, Sirichai
Noopetch, Preudtipong
Danpornprasert, Praniti
Mekviwattanawong, Sripetcharat
Fujitnirun, Chris
Lertpiriyasuwat, Cheewanan
Han, Win Min
Kerr, Stephen J.
Ruxrungtham, Kiat
Avihingsanon, Anchalee
author_sort Suwanpimolkul, Gompol
collection PubMed
description INTRODUCTION: Among high tuberculosis (TB) and HIV burden countries in Asia, tuberculosis preventive therapy (TPT) in people living with HIV (PLWH) has been underutilized despite its proven benefits independent of antiretroviral therapy (ART). Therefore, we determined the incidence of active TB and mortality among 9179 adult PLWH who attended and received ART from 15 tertiary care hospitals across Thailand. METHODS: A retrospective study was conducted in 2018 using follow‐up data from 1999 to 2018. The primary endpoint was incident TB disease after ART initiation. Factors associated with TB incidence were analysed using competing risk regression. The Kaplan–Meier method was used to estimate mortality after ART initiation. RESULTS: During a median of 5.1 years of ART (IQR 2.2–9.5 years), 442 (4.8%) PLWH developed TB (TB/HIV), giving an overall incidence of 750 (95% CI 683–823) per 100,000 persons‐year of follow up (PYFU). In multivariate analysis, lower CD4 at ART initiation (≤100 cells/mm(3), adjusted sub‐distribution hazard ratio [aSHR]: 2.08, 95% CI, 1.47–2.92; 101–200 cells/mm(3), aSHR: 2.21, 95% CI, 1.54–3.16; 201–350 cells/mm(3), aSHR: 1.59, 95% CI, 1.11–2.28 vs. >350 cells/mm(3)), male sex (aSHR: 1.40, 95% CI, 1.11–1.78), lower body weight (<50 kg, aSHR: 1.52, 95% CI, 1.17–1.95) and prior TB event (aSHR: 3.50, 95% CI, 2.72–4.52) were associated with TB incidence. PLWH with HIV RNA ≥50 copies/ml had 5–9 times higher risk of active TB disease higher than those with HIV RNA <50 copies/ml at the same CD4 level. The risk for developing TB was remarkably high during the initial period of ART (175,511 per 100,000 PYFU at<3 months) and was comparable to the general population after 10 years of ART (151 per 100,000 PYFU). TB/HIV had higher mortality (10% vs. 5%) and poorer HIV treatment outcomes: HIV RNA <50 copies/ml (63.8% vs. 82.8%), CD4 cells count (317 vs. 508 cells/mm(3)) at the most recent visit. CONCLUSIONS: In this high TB burden country, TB incidence was remarkably high during the first few years after ART initiation and thereafter decreased significantly. Rapid ART initiation and appropriate TPT can be potential key interventions to tackle the TB epidemic and reduce mortality among PLWH in TB/HIV high burden settings.
format Online
Article
Text
id pubmed-8982319
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89823192022-04-11 Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy Suwanpimolkul, Gompol Gatechompol, Sivaporn Kawkitinarong, Kamon Ueaphongsukkit, Thornthun Sophonphan, Jiratchaya Siriyakorn, Nirada Jirajariyavej, Supunnee Khusuwan, Suwimon Panarat, Palakorn Wannalerdsakun, Surat Saetiew, Natcha Chayangsu, Sunee Wiwatrojanagul, Sirichai Noopetch, Preudtipong Danpornprasert, Praniti Mekviwattanawong, Sripetcharat Fujitnirun, Chris Lertpiriyasuwat, Cheewanan Han, Win Min Kerr, Stephen J. Ruxrungtham, Kiat Avihingsanon, Anchalee J Int AIDS Soc Research Articles INTRODUCTION: Among high tuberculosis (TB) and HIV burden countries in Asia, tuberculosis preventive therapy (TPT) in people living with HIV (PLWH) has been underutilized despite its proven benefits independent of antiretroviral therapy (ART). Therefore, we determined the incidence of active TB and mortality among 9179 adult PLWH who attended and received ART from 15 tertiary care hospitals across Thailand. METHODS: A retrospective study was conducted in 2018 using follow‐up data from 1999 to 2018. The primary endpoint was incident TB disease after ART initiation. Factors associated with TB incidence were analysed using competing risk regression. The Kaplan–Meier method was used to estimate mortality after ART initiation. RESULTS: During a median of 5.1 years of ART (IQR 2.2–9.5 years), 442 (4.8%) PLWH developed TB (TB/HIV), giving an overall incidence of 750 (95% CI 683–823) per 100,000 persons‐year of follow up (PYFU). In multivariate analysis, lower CD4 at ART initiation (≤100 cells/mm(3), adjusted sub‐distribution hazard ratio [aSHR]: 2.08, 95% CI, 1.47–2.92; 101–200 cells/mm(3), aSHR: 2.21, 95% CI, 1.54–3.16; 201–350 cells/mm(3), aSHR: 1.59, 95% CI, 1.11–2.28 vs. >350 cells/mm(3)), male sex (aSHR: 1.40, 95% CI, 1.11–1.78), lower body weight (<50 kg, aSHR: 1.52, 95% CI, 1.17–1.95) and prior TB event (aSHR: 3.50, 95% CI, 2.72–4.52) were associated with TB incidence. PLWH with HIV RNA ≥50 copies/ml had 5–9 times higher risk of active TB disease higher than those with HIV RNA <50 copies/ml at the same CD4 level. The risk for developing TB was remarkably high during the initial period of ART (175,511 per 100,000 PYFU at<3 months) and was comparable to the general population after 10 years of ART (151 per 100,000 PYFU). TB/HIV had higher mortality (10% vs. 5%) and poorer HIV treatment outcomes: HIV RNA <50 copies/ml (63.8% vs. 82.8%), CD4 cells count (317 vs. 508 cells/mm(3)) at the most recent visit. CONCLUSIONS: In this high TB burden country, TB incidence was remarkably high during the first few years after ART initiation and thereafter decreased significantly. Rapid ART initiation and appropriate TPT can be potential key interventions to tackle the TB epidemic and reduce mortality among PLWH in TB/HIV high burden settings. John Wiley and Sons Inc. 2022-04-05 /pmc/articles/PMC8982319/ /pubmed/35384317 http://dx.doi.org/10.1002/jia2.25900 Text en © 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Suwanpimolkul, Gompol
Gatechompol, Sivaporn
Kawkitinarong, Kamon
Ueaphongsukkit, Thornthun
Sophonphan, Jiratchaya
Siriyakorn, Nirada
Jirajariyavej, Supunnee
Khusuwan, Suwimon
Panarat, Palakorn
Wannalerdsakun, Surat
Saetiew, Natcha
Chayangsu, Sunee
Wiwatrojanagul, Sirichai
Noopetch, Preudtipong
Danpornprasert, Praniti
Mekviwattanawong, Sripetcharat
Fujitnirun, Chris
Lertpiriyasuwat, Cheewanan
Han, Win Min
Kerr, Stephen J.
Ruxrungtham, Kiat
Avihingsanon, Anchalee
Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
title Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
title_full Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
title_fullStr Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
title_full_unstemmed Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
title_short Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
title_sort incidence of active tuberculosis among people living with hiv receiving long‐term antiretroviral therapy in high tb/hiv burden settings in thailand: implication for tuberculosis preventive therapy
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982319/
https://www.ncbi.nlm.nih.gov/pubmed/35384317
http://dx.doi.org/10.1002/jia2.25900
work_keys_str_mv AT suwanpimolkulgompol incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT gatechompolsivaporn incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT kawkitinarongkamon incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT ueaphongsukkitthornthun incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT sophonphanjiratchaya incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT siriyakornnirada incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT jirajariyavejsupunnee incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT khusuwansuwimon incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT panaratpalakorn incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT wannalerdsakunsurat incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT saetiewnatcha incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT chayangsusunee incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT wiwatrojanagulsirichai incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT noopetchpreudtipong incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT danpornprasertpraniti incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT mekviwattanawongsripetcharat incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT fujitnirunchris incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT lertpiriyasuwatcheewanan incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT hanwinmin incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT kerrstephenj incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT ruxrungthamkiat incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT avihingsanonanchalee incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy
AT incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy